gel, 2004). Nevertheless, the possibility that the heart can be repaired is not so far fetched. Zebrafish hearts will regenCardiac myocyte cell loss related to myocardial infarcerate functioning myocardium when injured (Poss et al., tion is the most common cause of congestive heart fail-2002). Like the amphibian limb, the zebrafish heart apure in the United States (Braunwald, 1997). Heart failure pears to regenerate by forming a blastema at the site is the most common diagnosis of hospitalized patients of injury where de-differentiation of cardiac myocytes in the United States, and the prevalence is increasing produces proliferative myoblasts. However, no similar response to injury has been observed in mammalian as the population ages. While advances in the prevenhearts. Perhaps the ability to regenerate tissue in sevtion and treatment of atherosclerotic heart disease eral organs, including the heart, has been lost or diminhave reduced cardiovascular morbidity, once damage ished through evolution in parallel with the emergence to the heart has occurred present therapies rarely result of increased complexity of patterning and function. If in long-term improvement of cardiac function (Jessup so, defining the molecular basis of cardiac regeneration and Brozena, 2003). Despite the application of new in amphibian species may provide fundamental insights medical therapies, the prognosis of patients diagnosed into cardiac myocyte regeneration. with heart failure is comparable to patients diagnosed But is the adult mammalian heart completely unable with many forms of cancer. Usually, inexorable decline to regenerate cardiac muscle? Several recent reports ensues from the time of diagnosis. Amidst the present raise hope that cardiac progenitor cells exist within the era of regenerative medicine and excitement regarding adult heart. Recent work from the laboratory of Kenstem cell therapies, attention has focused on the possineth Chien takes advantage of a new paradigm emergbility of re-growing heart muscle in order to treat ing from the study of developmental cardiology to idencardiac failure (Chien, 2004). 
differentiated cardiac myocytes including responsiveness to β-adrenergic agonists.
However, a number of questions remain to be addressed before the therapeutic potential of this population can be assessed. Isl1 + cells have been isolated only from very young animal and human specimens, and the number of progenitor cells falls rapidly over the first few weeks of life. Do any resident progenitors persist into adulthood? Most of the ex vivo studies were performed on cells taken from 1-to 5-day-old animals, where only 500-600 isl1 + cells were identified per rat heart. The rare isl1 + cells identified at later times were not evaluated for their ability to expand or differentiate. Importantly, isl1 + cells were identified in multiple organisms including humans, but the single human sample examined beyond 8 days of age (at 148 days) failed to reveal any isl1 progenitors.
The factors that influence the ability to expand and differentiate these resident progenitors need to be elucidated. Are these cells multipotential? Although a high percentage (25%) of cultured cells expressed troponin T under differentiation conditions, only 2.3% displayed calcium transients characteristic of cardiac myocytes. A clearer understanding of the cell surface and secreted factors provided by co-cultured myocytes will allow for enhanced efficiency of cardiomyocyte differentiation. Can these factors be identified and/or enriched obviating the need for co-culture? Questions of multipotentiality, , the reUnlike some other putative resident cardiac progenitor ceptor for stem cell factor (SCF). In the adult rat myopopulations (see below), these cells fail to express stem cardium, Lin − c-kit POS cells are relatively rare (w1 per cell antigen 1 (Sca-1), CD31, or c-kit, though they do 10 4 myocytes) but more prevalent than the isl1 + progenexpress Nkx2-5 and GATA4. Importantly, Chien and coitors described above. The cells are roughly one-tenth workers have shown that these cells can differentiate the size of cardiac myocytes. Cardiac c-kit POS cells isointo cardiac myocytes both in vivo, using an inducible lated by FACS sorting are heterogeneous with rare cre-lox system, and in vitro. Isl1 + cells from hearts can (7%-10%) cells expressing Nkx2-5, GATA4, and Mef2, be expanded in culture. Co-culture with cardiac myoand fewer still (0.5%) expressing genes encoding sarcytes leads to expression of terminal differentiation markers and electrophysiologic characteristics of fully comeric proteins. These cells retain these characteris- ing a cardiac resident stem cell niche is lacking. As described in Table 1 , the resident population of Despite the enticing therapeutic potential of cardiac reisl1 + cardiac progenitors described by Chien and colgeneration, a host of important questions remain to be leagues differs fundamentally from SP cells, from the answered before rational approaches will allow for optic-kit POS cardiac stem cells, and from the cardiac Scamal clinical utility. 1 + progenitors. The resident population of isl1 + cells in the heart probably represents specified cardiac progenitors or "cardioblasts." By contrast, GATA4 and
